ID   TRAF6_RAT               Reviewed;         530 AA.
AC   B5DF45;
DT   09-FEB-2010, integrated into UniProtKB/Swiss-Prot.
DT   14-OCT-2008, sequence version 1.
DT   02-OCT-2024, entry version 132.
DE   RecName: Full=TNF receptor-associated factor 6;
DE            EC=2.3.2.27;
DE   AltName: Full=E3 ubiquitin-protein ligase TRAF6;
DE   AltName: Full=RING-type E3 ubiquitin transferase TRAF6 {ECO:0000305};
GN   Name=Traf6;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: E3 ubiquitin ligase that, together with UBE2N and UBE2V1,
CC       mediates the synthesis of 'Lys-63'-linked-polyubiquitin chains
CC       conjugated to proteins, such as ECSIT, IKBKG, IRAK1, AKT1 and AKT2.
CC       Also mediates ubiquitination of free/unanchored polyubiquitin chain
CC       that leads to MAP3K7 activation. Leads to the activation of NF-kappa-B
CC       and JUN (By similarity). Seems to also play a role in dendritic cells
CC       (DCs) maturation and/or activation (By similarity). Represses c-Myb-
CC       mediated transactivation, in B-lymphocytes. Adapter protein that seems
CC       to play a role in signal transduction initiated via TNF receptor, IL-1
CC       receptor and IL-17 receptor (By similarity). Regulates osteoclast
CC       differentiation by mediating the activation of adapter protein complex
CC       1 (AP-1) and NF-kappa-B, in response to RANK-L stimulation. Together
CC       with MAP3K8, mediates CD40 signals that activate ERK in B-cells and
CC       macrophages, and thus may play a role in the regulation of
CC       immunoglobulin production (By similarity). Participates also in the TCR
CC       signaling by ubiquitinating LAT (By similarity).
CC       {ECO:0000250|UniProtKB:P70196, ECO:0000250|UniProtKB:Q9Y4K3}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27;
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Homotrimer. Homooligomer. N-terminal region is dimeric while
CC       C-terminal region is trimeric; maybe providing a mode of
CC       oligomerization. Upon IL1B treatment, forms a complex with PELI1,
CC       IRAK1, IRAK4 and MYD88; this complex recruits MAP3K7/TAK1, TAB1 and
CC       TAB2 to mediate NF-kappa-B activation. Direct binding of SMAD6 to PELI1
CC       prevents the complex formation and hence negatively regulates IL1R-TLR
CC       signaling and eventually NF-kappa-B-mediated gene expression. Binds to
CC       TNFRSF5/CD40 and TNFRSF11A/RANK. Associates with NGFR, TNFRSF17, IRAK2,
CC       IRAK3, RIPK2, MAP3K1, MAP3K5, MAP3K14, CSK, TRAF, TRAF-interacting
CC       protein TRIP and TNF receptor associated protein TDP2. Interacts with
CC       IL17R. Interacts with SQSTM1 bridging NTRK1 and NGFR. Forms a ternary
CC       complex with SQSTM1 and PRKCZ (By similarity). Interacts with PELI2 and
CC       PELI3. Binds UBE2V1. Interacts with TAX1BP1; this interaction mediates
CC       deubiquitination of TRAF6 and inhibition of NF-kappa-B activation (By
CC       similarity). Interacts with ZNF675. Interacts with ARRB1 and ARRB2.
CC       Interacts with MAP3K7 and TAB1/MAP3K7IP1; during IL-1 signaling.
CC       Interacts with UBE2N. Interacts with TGFBR1, HDAC1 and RANGAP1.
CC       Interacts with AKT1, AKT2 and AKT3. Interacts (via TRAF domains) with
CC       NUMBL (via C-terminal). Interacts with RBCK1. Interacts with LIMD1 (via
CC       LIM domains) (By similarity). Interacts with RSAD2/viperin (By
CC       similarity). Interacts (via C-terminus) with EIF2AK2/PKR (via the
CC       kinase catalytic domain) (By similarity). Interacts with ZFAND5.
CC       Interacts with IL1RL1. Interacts with TRAFD1. Interacts with AJUBA.
CC       Interacts with MAVS/IPS1. Interacts (via TRAF domains) with DYNC2I2
CC       (via WD domains). Interacts with IFIT3 (via N-terminus). Interacts with
CC       TICAM2. Interacts with CARD14. Interacts with CD40 and MAP3K8; the
CC       interaction is required for ERK activation (By similarity). Interacts
CC       with TICAM1 and this interaction is enhanced in the presence of WDFY1.
CC       Interacts with TANK; this interaction increases in response to DNA
CC       damage. Interacts with USP10; this interaction increases in response to
CC       DNA damage. Interacts with ZC3H12A; this interaction increases in
CC       response to DNA damage and is stimulated by TANK (By similarity).
CC       Interacts with WDFY3 (By similarity). Interacts with TRIM13 (By
CC       similarity). Interacts with GPS2 (By similarity). Interacts (via C-
CC       terminus) with SASH1. Interacts with LRRC19. Interacts with IL17RA and
CC       TRAF3IP2. Interacts with TOMM70. Interacts with AMBRA1; interaction is
CC       required to mediate 'Lys-63'-linked ubiquitination of ULK1 (By
CC       similarity). Interacts with CRBN; this interaction inhibits TLR4-
CC       mediated signaling by preventing TRAF6-mediated ubiquitination of ECSIT
CC       (By similarity). {ECO:0000250|UniProtKB:P70196,
CC       ECO:0000250|UniProtKB:Q9Y4K3}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9Y4K3}.
CC       Cytoplasm, cell cortex {ECO:0000250|UniProtKB:Q9Y4K3}. Nucleus
CC       {ECO:0000250|UniProtKB:Q9Y4K3}. Lipid droplet
CC       {ECO:0000250|UniProtKB:P70196}. Note=RSAD2/viperin recruits it to the
CC       lipid droplet. {ECO:0000250|UniProtKB:P70196}.
CC   -!- DOMAIN: The coiled coil domain mediates homo- and hetero-
CC       oligomerization. {ECO:0000250|UniProtKB:Q9Y4K3}.
CC   -!- DOMAIN: The MATH/TRAF domain binds to receptor cytoplasmic domains.
CC       {ECO:0000250|UniProtKB:Q9Y4K3}.
CC   -!- PTM: Sumoylated on Lys-124, Lys-142 and Lys-461 with SUMO1.
CC       {ECO:0000250|UniProtKB:Q9Y4K3}.
CC   -!- PTM: Polyubiquitinated on Lys-124 by TRAF3IP2; after cell stimulation
CC       with IL17A (By similarity). Polyubiquitinated; after cell stimulation
CC       with IL1B or TGFB. This ligand-induced cell stimulation leads to
CC       dimerization/oligomerization of TRAF6 molecules, followed by auto-
CC       ubiquitination which involves UBE2N and UBE2V1 and leads to TRAF6
CC       activation. This 'Lys-63' site-specific poly-ubiquitination appears to
CC       be associated with the activation of signaling molecules. Endogenous
CC       autoubiquitination occurs only for the cytoplasmic form.
CC       Deubiquitinated by USP10 in a TANK-dependent manner, leading to the
CC       negative regulation of NF-kappa-B signaling upon DNA damage. LRRC19
CC       induces 'Lys-63' ubiquitination (By similarity). Ubiquitinated at Lys-
CC       327 by the SCF(FBXL2) complex, leading to its degradation by the
CC       proteasome (By similarity). {ECO:0000250|UniProtKB:P70196,
CC       ECO:0000250|UniProtKB:Q9Y4K3}.
CC   -!- SIMILARITY: Belongs to the TNF receptor-associated factor family. A
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH473949; EDL79625.1; -; Genomic_DNA.
DR   EMBL; BC168921; AAI68921.1; -; mRNA.
DR   RefSeq; NP_001101224.1; NM_001107754.2.
DR   AlphaFoldDB; B5DF45; -.
DR   SMR; B5DF45; -.
DR   BioGRID; 259875; 10.
DR   STRING; 10116.ENSRNOP00000006148; -.
DR   PhosphoSitePlus; B5DF45; -.
DR   PaxDb; 10116-ENSRNOP00000006148; -.
DR   PeptideAtlas; B5DF45; -.
DR   Ensembl; ENSRNOT00000006148.6; ENSRNOP00000006148.4; ENSRNOG00000004639.6.
DR   Ensembl; ENSRNOT00055000231; ENSRNOP00055000126; ENSRNOG00055000156.
DR   Ensembl; ENSRNOT00060004720; ENSRNOP00060003381; ENSRNOG00060002915.
DR   Ensembl; ENSRNOT00065027677; ENSRNOP00065021798; ENSRNOG00065016611.
DR   GeneID; 311245; -.
DR   KEGG; rno:311245; -.
DR   UCSC; RGD:1306853; rat.
DR   AGR; RGD:1306853; -.
DR   CTD; 7189; -.
DR   RGD; 1306853; Traf6.
DR   eggNOG; KOG0297; Eukaryota.
DR   GeneTree; ENSGT00940000155426; -.
DR   HOGENOM; CLU_021061_5_0_1; -.
DR   InParanoid; B5DF45; -.
DR   OrthoDB; 2913784at2759; -.
DR   PhylomeDB; B5DF45; -.
DR   TreeFam; TF321154; -.
DR   Reactome; R-RNO-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-RNO-166058; MyD88:MAL(TIRAP) cascade initiated on plasma membrane.
DR   Reactome; R-RNO-202424; Downstream TCR signaling.
DR   Reactome; R-RNO-205043; NRIF signals cell death from the nucleus.
DR   Reactome; R-RNO-209543; p75NTR recruits signalling complexes.
DR   Reactome; R-RNO-209560; NF-kB is activated and signals survival.
DR   Reactome; R-RNO-2871837; FCERI mediated NF-kB activation.
DR   Reactome; R-RNO-450302; activated TAK1 mediates p38 MAPK activation.
DR   Reactome; R-RNO-450321; JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1.
DR   Reactome; R-RNO-5607764; CLEC7A (Dectin-1) signaling.
DR   Reactome; R-RNO-5689880; Ub-specific processing proteases.
DR   Reactome; R-RNO-5689896; Ovarian tumor domain proteases.
DR   Reactome; R-RNO-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   Reactome; R-RNO-9020702; Interleukin-1 signaling.
DR   Reactome; R-RNO-937039; IRAK1 recruits IKK complex.
DR   Reactome; R-RNO-937042; IRAK2 mediated activation of TAK1 complex.
DR   Reactome; R-RNO-937072; TRAF6-mediated induction of TAK1 complex within TLR4 complex.
DR   Reactome; R-RNO-9645460; Alpha-protein kinase 1 signaling pathway.
DR   Reactome; R-RNO-975138; TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation.
DR   Reactome; R-RNO-975144; IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation.
DR   Reactome; R-RNO-975163; IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation.
DR   Reactome; R-RNO-9758274; Regulation of NF-kappa B signaling.
DR   Reactome; R-RNO-975871; MyD88 cascade initiated on plasma membrane.
DR   UniPathway; UPA00143; -.
DR   PRO; PR:B5DF45; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   Proteomes; UP000234681; Chromosome 3.
DR   Bgee; ENSRNOG00000004639; Expressed in jejunum and 18 other cell types or tissues.
DR   GO; GO:0035631; C:CD40 receptor complex; ISO:RGD.
DR   GO; GO:0005938; C:cell cortex; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0009898; C:cytoplasmic side of plasma membrane; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005811; C:lipid droplet; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0098794; C:postsynapse; IDA:SynGO.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0042826; F:histone deacetylase binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0043422; F:protein kinase B binding; ISO:RGD.
DR   GO; GO:0005164; F:tumor necrosis factor receptor binding; IEA:InterPro.
DR   GO; GO:0031624; F:ubiquitin conjugating enzyme binding; ISO:RGD.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; ISO:RGD.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; ISS:UniProtKB.
DR   GO; GO:0034450; F:ubiquitin-ubiquitin ligase activity; ISO:RGD.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0009887; P:animal organ morphogenesis; ISO:RGD.
DR   GO; GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; ISO:RGD.
DR   GO; GO:0140374; P:antiviral innate immune response; ISO:RGD.
DR   GO; GO:0000045; P:autophagosome assembly; ISO:RGD.
DR   GO; GO:0046849; P:bone remodeling; ISO:RGD.
DR   GO; GO:0045453; P:bone resorption; ISO:RGD.
DR   GO; GO:0007249; P:canonical NF-kappaB signal transduction; ISO:RGD.
DR   GO; GO:0048468; P:cell development; ISO:RGD.
DR   GO; GO:1904385; P:cellular response to angiotensin; IEP:RGD.
DR   GO; GO:0071345; P:cellular response to cytokine stimulus; ISO:RGD.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IEP:RGD.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; ISO:RGD.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IMP:RGD.
DR   GO; GO:0002753; P:cytoplasmic pattern recognition receptor signaling pathway; ISO:RGD.
DR   GO; GO:0006974; P:DNA damage response; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; ISO:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0045087; P:innate immune response; IBA:GO_Central.
DR   GO; GO:0070498; P:interleukin-1-mediated signaling pathway; IMP:RGD.
DR   GO; GO:0097400; P:interleukin-17-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0038173; P:interleukin-17A-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0038172; P:interleukin-33-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0007254; P:JNK cascade; IMP:RGD.
DR   GO; GO:0031663; P:lipopolysaccharide-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0043011; P:myeloid dendritic cell differentiation; ISO:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0001843; P:neural tube closure; ISO:RGD.
DR   GO; GO:0038061; P:non-canonical NF-kappaB signal transduction; ISO:RGD.
DR   GO; GO:0042475; P:odontogenesis of dentin-containing tooth; ISO:RGD.
DR   GO; GO:0001503; P:ossification; ISO:RGD.
DR   GO; GO:0030316; P:osteoclast differentiation; ISO:RGD.
DR   GO; GO:0043123; P:positive regulation of canonical NF-kappaB signal transduction; ISS:UniProtKB.
DR   GO; GO:0032735; P:positive regulation of interleukin-12 production; ISO:RGD.
DR   GO; GO:0032743; P:positive regulation of interleukin-2 production; ISO:RGD.
DR   GO; GO:0032755; P:positive regulation of interleukin-6 production; ISO:RGD.
DR   GO; GO:1904996; P:positive regulation of leukocyte adhesion to vascular endothelial cell; ISO:RGD.
DR   GO; GO:0031666; P:positive regulation of lipopolysaccharide-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0045672; P:positive regulation of osteoclast differentiation; ISO:RGD.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IMP:RGD.
DR   GO; GO:0002726; P:positive regulation of T cell cytokine production; ISO:RGD.
DR   GO; GO:0042102; P:positive regulation of T cell proliferation; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0032481; P:positive regulation of type I interferon production; ISO:RGD.
DR   GO; GO:0051865; P:protein autoubiquitination; ISO:RGD.
DR   GO; GO:0070534; P:protein K63-linked ubiquitination; ISS:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; ISO:RGD.
DR   GO; GO:0016567; P:protein ubiquitination; ISO:RGD.
DR   GO; GO:0042981; P:regulation of apoptotic process; IEA:InterPro.
DR   GO; GO:0043122; P:regulation of canonical NF-kappaB signal transduction; IBA:GO_Central.
DR   GO; GO:0002637; P:regulation of immunoglobulin production; ISO:RGD.
DR   GO; GO:0098696; P:regulation of neurotransmitter receptor localization to postsynaptic specialization membrane; ISO:RGD.
DR   GO; GO:0140252; P:regulation protein catabolic process at postsynapse; IDA:SynGO.
DR   GO; GO:0070555; P:response to interleukin-1; ISO:RGD.
DR   GO; GO:0002931; P:response to ischemia; IEP:RGD.
DR   GO; GO:0007165; P:signal transduction; ISO:RGD.
DR   GO; GO:0007416; P:synapse assembly; IDA:SynGO.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; ISO:RGD.
DR   GO; GO:0042088; P:T-helper 1 type immune response; ISO:RGD.
DR   GO; GO:0034142; P:toll-like receptor 4 signaling pathway; ISO:RGD.
DR   GO; GO:0033209; P:tumor necrosis factor-mediated signaling pathway; IBA:GO_Central.
DR   CDD; cd03776; MATH_TRAF6; 1.
DR   CDD; cd16643; mRING-HC-C3HC3D_TRAF6; 1.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 3.
DR   InterPro; IPR002083; MATH/TRAF_dom.
DR   InterPro; IPR012227; TNF_rcpt-assoc_TRAF_met.
DR   InterPro; IPR008974; TRAF-like.
DR   InterPro; IPR049342; TRAF1-6_MATH_dom.
DR   InterPro; IPR037309; TRAF6_MATH.
DR   InterPro; IPR027139; TRAF6_RING-HC.
DR   InterPro; IPR041310; TRAF6_Z2.
DR   InterPro; IPR018957; Znf_C3HC4_RING-type.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   InterPro; IPR001293; Znf_TRAF.
DR   PANTHER; PTHR10131; TNF RECEPTOR ASSOCIATED FACTOR; 1.
DR   PANTHER; PTHR10131:SF94; TNF RECEPTOR-ASSOCIATED FACTOR 6; 1.
DR   Pfam; PF21355; TRAF-mep_MATH; 1.
DR   Pfam; PF18048; TRAF6_Z2; 1.
DR   Pfam; PF00097; zf-C3HC4; 1.
DR   Pfam; PF02176; zf-TRAF; 1.
DR   PIRSF; PIRSF015614; TRAF; 1.
DR   SMART; SM00061; MATH; 1.
DR   SMART; SM00184; RING; 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   SUPFAM; SSF49599; TRAF domain-like; 3.
DR   PROSITE; PS50144; MATH; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
DR   PROSITE; PS50145; ZF_TRAF; 2.
PE   2: Evidence at transcript level;
KW   Coiled coil; Cytoplasm; DNA damage; Immunity; Isopeptide bond;
KW   Lipid droplet; Metal-binding; Nucleus; Osteopetrosis; Reference proteome;
KW   Repeat; Transferase; Ubl conjugation; Ubl conjugation pathway; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..530
FT                   /note="TNF receptor-associated factor 6"
FT                   /id="PRO_0000391611"
FT   DOMAIN          358..507
FT                   /note="MATH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00129"
FT   ZN_FING         70..109
FT                   /note="RING-type; degenerate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   ZN_FING         150..202
FT                   /note="TRAF-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00207"
FT   ZN_FING         203..259
FT                   /note="TRAF-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00207"
FT   REGION          1..362
FT                   /note="Interaction with TAX1BP1"
FT                   /evidence="ECO:0000250"
FT   REGION          363..530
FT                   /note="Interaction with TANK"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y4K3"
FT   COILED          302..356
FT                   /evidence="ECO:0000255"
FT   CROSSLNK        124
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO); alternate"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        124
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y4K3"
FT   CROSSLNK        142
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        327
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P70196"
FT   CROSSLNK        461
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   530 AA;  60253 MW;  5DCC4DEB4CF2DA4F CRC64;
     MSLLNCENSC ASSQSSSDCC AAMANSCSAA MKDDSVSGCV STGNLSSSFM EEIQGYDVEF
     DPPLESKYEC PICLMALREA VQTPCGHRFC KACITKSIRD AGHKCPVDNE ILLENQLFPD
     NFAKREILSL TVKCPNKGCV QKMELRHLED HQVHCEFALV ICPQCQRFFQ KCQINKHIIE
     DCPRRQVSCV NCAVPMPYEE KEIHDQSCPL ANIICEYCGT ILIREQMPNH YDLDCPTAPV
     PCTFSVFGCH EKMQRNHLAR HLQENTQLHM RLLAQAVHNV NLSLRPCDAS SPSRGCRPED
     PNYEETVKQL EGRLVRQDHQ IRELTAKMET QSMHVSELKR TIRSLEDKVA EMEAQQCNGI
     YIWKIGNFGM HLKSQEEERP VVIHSPGFYT GRPGYKLCMR LHLQLPTAQR CANYISLFVH
     TMQGEYDSHL PWPFQGTIRL TILDQSEAVI RQNHEEVMDA KPELLAFQRP TIPRNPKGFG
     YVTFMHLEAL RQGTFIKDDT LLVRCEVSTR FDMGGLRKEG FQPRSTDAGV
//
